Last 65.50 INR
Change Today -0.65 / -0.98%
Volume 248.5K
BLP On Other Exchanges
Symbol
Exchange
Natl India
As of 7:05 AM 07/23/14 All times are local (Market data is delayed by at least 15 minutes).

bal pharma ltd (BLP) Snapshot

Open
66.00
Previous Close
66.15
Day High
69.00
Day Low
64.15
52 Week High
07/23/14 - 69.00
52 Week Low
08/20/13 - 14.05
Market Cap
843.1M
Average Volume 10 Days
201.6K
EPS TTM
0.39
Shares Outstanding
12.9M
EX-Date
09/12/14
P/E TM
168.3x
Dividend
1.00
Dividend Yield
1.15%
Current Stock Chart for BAL PHARMA LTD (BLP)

Related News

No related news articles were found.

bal pharma ltd (BLP) Related Businessweek News

No Related Businessweek News Found

bal pharma ltd (BLP) Details

Bal Pharma Limited manufactures and markets pharmaceutical formulations and active pharmaceutical ingredients (API) in India. The company offers prescription drugs, generics, OTC products, intravenous infusion products, and bulk actives. It also provides a range of APIs for various therapeutic areas, including acne treatment, diuretic, anti-histamine, anti-inflammatory, anti-diabetic, sedative/hypnotic, anti-allergy, neuropathic pain, urinary incontinence, anti-convulsant, and insomnia. The company also provides ayurvedic products comprising ANARSHA for regularize bowl movement; Ashwamed for sexual and general debility; AYURFINE and AYURFINE forte anti arthritics for osteoarthritis, rheumatoid arthritis, and spondylitis; Ayursulin for managing diabetes; IMMUWIN, an immune building supplement; and Lipived for reducing cholesterol. Its ayurvedic products also consists of MENOLEAP capsules and syrup for menstrual disorders; PROLIFE, which provides life to ailing liver; BALPRO SYRUP for stable and synchronized liver functions; PROSTOWIN for benign prostatic hyperplasia; STONEX for expulsion of kidney stones; Sujirna for digestion; Suswas, an antallergic/antiasthamatic product; and Balvac, a mild laxative. The company also exports its products to Europe, Latin America, Africa, the Middle East, and Asian markets. Bal Pharma Limited was incorporated in 1987 and is based in Bengaluru, India.

Founded in 1987

bal pharma ltd (BLP) Top Compensated Officers

Managing Director, Executive Director, Member...
Total Annual Compensation: 5.4M
Whole-Time Director and Chairman of Banking T...
Total Annual Compensation: 2.4M
Compensation as of Fiscal Year 2013.

bal pharma ltd (BLP) Key Developments

B.N.Pranesh Ceases to Be the Nominee Director of EXIM Bank on the Board of Bal Pharma Limited

Bal Pharma Limited has announced that as per the communication received from Export Import Bank of India, Mumbai, Mr. B.N.Pranesh ceases to be the nominee Director of EXIM Bank on the Board of company, with immediate effect.

Bal Pharma Limited Reports Audited Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2014; Recommends Dividend

Bal Pharma Limited reported audited earnings results for the fourth quarter and full year ended March 31, 2014. For the quarter, the company reported net sales of INR 466.207 million compared to INR 415.563 million reported in the same period last year. Profit from operations before other income, interest and exceptional items was INR 33.905 million against INR 39.323 million reported last year. Profit from ordinary activities before tax was INR 19.440 million against INR 22.887 million reported last year. Net profit was INR 13.577 million or INR 1.21 per diluted share against INR 21.219 million or INR 2.01 per diluted share reported last year. For the year, the company reported net sales of INR 1,734.140 million compared to INR 1,443.036 million reported in the same period last year. Profit from operations before other income, interest and exceptional items was INR 131.371 million against INR 124.066 million reported last year. Profit from ordinary activities before tax was INR 66.260 million against INR 50.891 million reported last year. Net profit was INR 50.721 million or INR 4.60 per diluted share against INR 42.835 million or INR 4.05 per diluted share reported last year The company announced that the Board of Directors of the company at its meeting held on May 28, 2014, has recommended payment of dividend of INR 1 (10%) per equity share of INR 10 each.

Bal Pharma Limited to Report Q4, 2014 Results on May 28, 2014

Bal Pharma Limited announced that they will report Q4, 2014 results on May 28, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BLP:IN 65.50 INR -0.65

BLP Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for BLP.
View Industry Companies
 

Industry Analysis

BLP

Industry Average

Valuation BLP Industry Range
Price/Earnings 14.3x
Price/Sales 0.4x
Price/Book 1.4x
Price/Cash Flow 8.6x
TEV/Sales 0.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BAL PHARMA LTD, please visit www.balpharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.